During the past two decades, linkage analysis has been phenomenally successful in localizing Mendelian disease genes. Linkage disequilibrium (LD) analysis, which effectively incorporates the effects of many past generations of recombination, has often been instrumental in the final phases of gene localization (Feder et al. 1996; Hästbacka et al. 1994; Kerem et al. 1989 ). These successes have fueled hopes that similar approaches will be effective in localizing genes underlying susceptibility to common, complex diseases.
With the exception of Mendelian subsets of common diseases (e.g., BRCA1 and BRCA2 for breast cancer, APC for colon cancer, the LDL receptor gene for heart disease), progress on this front has been limited. Typically, a nonparametric linkage analysis, such as a sib-pair analysis, will implicate several genetic regions as targets for further investigation. These regions, often 10-20 Mb in size, remain intractably large for effective positional cloning. It is now hoped that LD approaches, using hundreds of thousands of new polymorphic markers, will overcome this impasse (Risch and Merikangas 1996) .
The rationale underlying LD mapping of complex disease genes is straightforward and similar to the justification for LD mapping of Mendelian disease genes. With both types of disease genes, the primary advantage of LD analysis remains its ability to use the effects of dozens or hundreds of past generations of recombination to achieve fine-scale gene localization (Jorde 1995) . An important difficulty, common to both types of disease genes, is that past historical events (admixture, genetic drift, multiple mutations, and natural selection) can disturb the relationship between LD and inter-locus physical distance. A major difference, of course, is that locus heterogeneity complicates the analysis of complex diseases and may be more extensive for these diseases than for most Mendelian diseases. Furthermore, allelic heterogeneity may be present at each locus. This heterogeneity, the scope of which is largely unknown, will limit the strength of association between a given polymorphism and an observable phenotype.
Despite these challenges, LD mapping holds considerable appeal, and there is great demand to resolve the genetics of complex diseases. Consequently, many new techniques have been devised to carry out LD analysis, often with a view toward mapping complex disease loci. The purpose of this review is to summarize these techniques and some of the issues surrounding their application. In particular, the evolutionary factors that can confound or enhance disequilibrium analysis will be discussed, and some thoughts will be offered on the optimal choice of markers and populations for LD analysis.
Linkage Disequilibrium Measures
Two-Locus Methods LD, simply defined, is the nonrandom association of alleles at linked loci. Although concepts of LD date to the early part of the twentieth century (Jennings 1917) , the first commonly used LD measure, D, was developed by Richard Lewontin some 35 years ago (Lewontin 1964) . For a pair of diallelic loci, A and B, this statistic measures the difference between two quantities: (1) the observed frequency of co-occurrence of an allele of A (A 1 ) and an allele of B (B 1 ) on the same chromosome and (2) the expected frequency of co-occurrence under linkage equilibrium. The observed frequency, denoted by P 11 , is the proportion of chromosomes on which alleles A 1 and B 1 co-occur in a population. The expected value of P 11 under linkage equilibrium is the product of the allele frequencies of A 1 and B 1 in the population. Thus, D = P 11 ‫מ‬ p 1 q 1 , where the allele frequencies are symbolized as follows: p 1 = f(A 1 ); p 2 = 1 ‫מ‬ p 1 = f(A 2 ); q 1 = f(B 1 ); q 2 = 1‫מ‬q 1 = f(B 2 ). If D differs significantly from zero, LD is said to exist. The degree of LD between two loci is dependent on both the recombination fraction, , and time in generations, t (e.g., since the origin of a new disease-causing mutation at time 0):
Thus, D will tend to be smaller when two loci are located further apart, and D will decrease through time as a result of recombination. D provides a simple indication of the frequency of recombination and, hence, the physical distance between two loci. Alternatively, if can be estimated, LD can be used to infer the age of a disease-causing mutation.
D is dependent on allele frequencies in the population: its maximum value is given by D max = min(p 1 q 2, p 2 q 1 ),whereas its minimum value, D min , is given by max(-p 1 q 1 , -p 2 q 2 ). D can be scaled as DЈ = D/D max (Lewontin 1964) . Another common scaling of D is to divide it by √(p 1 p 2 q 1 q 2 ) (Hill and Robertson 1968) . This quantity, commonly labeled R or ⌬, is equal to √ 2 /N, where the 2 statistic can be obtained from the 2 ‫ן‬ 2 table of haplotype frequencies (i.e., P 11 , P 12 , P 21 , and P 22 ), and N is the total number of haplotypes in the sample. This provides a means of testing the statistical significance of R. Alternatively, significance can be evaluated using permutation-based methods (Zaykin et al. 1995) . The latter approach is especially useful with multiallelic microsatellite loci that yield many possible two-locus genotypes. Although R can vary from -1 to 1, it is limited by the actual values of the allele frequencies, and thus, like D, it is a frequency-dependent measure.
Another common two-locus disequilibrium statistic, commonly labeled ␦, is similar to an attributable risk measure and is given by D/(q 1 P 22 ) (Bengtsson and Thomson 1981) , in which q 1 is the population frequency of a disease allele, B 1 , and P 22 is the frequency of chromosomes that contain marker allele A 2 and the normal allele, B 2 . Several comparative analyses of twolocus LD measures have shown that, in most circumstances, ␦ and DЈ give more reliable estimates of physical distance than do D and R because of the latter's dependence on allele frequencies (Ajioka et al. 1997; Devlin and Risch 1995; Guo 1997) . Devlin and Risch (1995) showed that ␦ is directly proportional to the recombination fraction and is thus a desirable measure of genetic distance. However, even ␦ can show allelefrequency dependence when multiple disease-causing mutations have occurred on different haplotype backgrounds (Guo 1997) .
The traditional LD measures, R and D, implicitly assume a constant population, as is implied by the well-known relationship E(R 2 ) = 1/(1 + 4 N e ), where N e is effective population size. Under a model of recombination-drift equilibrium, N e is proportional to the time since a new mutation occurred, giving rise to new disequilibrium (Hill and Robertson 1968; Kaplan et al. 1995) . However, most human populations have undergone rapid population growth. This led investigators to adapt the Luria-Delbrück model of bacterial mutation to the process of recombination in exponentially growing human populations (Hästbacka et al. 1992) . The P excess statistic derived by Hästbacka et al. is identical to ␦ (Devlin and Risch 1995) . Kaplan et al. (1995) devised a likelihood approach that simulates a growing population and gives more accurate confidence limits than does the method of Hästbacka et al. Rannala and Slatkin (1998) derived the sampling distribution for a diallelic marker closely linked to a lowfrequency mutation that arose once in a nonstationary population. Graham and Thompson (1998) applied coalescence theory to the problem of nonstationary populations and formulated a method that can account for any pattern of population growth.
Controlling for Stratification: The Transmission Disequilibrium Test and Its Variants
LD testing is typically carried out as a case-control comparison in which marker frequencies are compared in samples of affected individuals and unaffected controls. Case-control studies can be confounded by population stratification, and there are several empirical examples of this problem (Knowler et al. 1988; Reich et al. 1999 ). LD analysis is no exception to this difficulty, and various strategies have been devised to control for stratification. An early example is the haplotype relative risk (HRR) method (Falk and Rubinstein 1987) , which tests for association by defining the haplotype transmitted by a parent to an affected offspring as the "case" haplotype and the untransmitted parental haplotype as the "control". This ensures that case and control haplotypes come from the same population, reducing (but not eliminating) the potential for stratification. This test is also known, in modified form, as the transmission disequilibrium test, or TDT (Spielman et al. 1993) . The TDT tests for linkage in the presence of LD and eliminates stratification effects completely, but a disadvantage is that it uses only heterozygous parents. When there is no stratification, it is less powerful than the HRR, which uses both homozygous and heterozygous parents (Schaid 1998) . When there is stratification, the HRR (or similar tests such as AFBAC [Thomson 1995] ) is more likely to yield false positive results (Spielman and Ewens 1996) .
Numerous variants of the TDT have been devised, including extensions for multiallelic markers (Sham and Curtis 1995) , multiple marker loci (Wilson 1997) , quantitative disease loci (Allison 1997; , extended pedigrees (George et al. 1999) , and families in which only one parent (Sun et al. 1999; Weinberg 1999) or only siblings are available (Allison et al. 1999; Spielman and Ewens 1998; Teng and Risch 1999) . The sib-TDT is especially useful for diseases of late adulthood, in which multiple generations may not be available for study. However, it is somewhat less powerful than the traditional TDT (Schaid 1998) . Another variant of the sib-TDT examines allele-sharing patterns in sibs who are discordant for a trait (Boehnke and Langefeld 1998) . Again, this approach will be especially useful for late-onset traits in which multiple affected sibs may be difficult to collect.
In many LD-mapping studies, family data are already available because of their collection for an initial linkage analysis. It is thus practical to use the TDT in such situations to avoid the problem of stratification. It has been argued, however, that traditional case-control studies may be preferable to the TDT if family data are not already available . This is because the TDT is statistically only half as efficient as a case-control design and thus requires much more effort (i.e., the ascertainment of twice as many subjects) to gain an equivalent amount of information. Morton and Collins argue that stratification, which reduces the accuracy and power of the case-control design, is a problem only under rare circumstances. Although analyses of DNA forensic databases offer support for this assertion (National Research Council 1996) , the issue should be addressed with further empirical data. When the extent of stratification is unknown, a practical solution is to assess associations between multiple unlinked markers in case and control populations to test and correct for stratification effects (Pritchard and Rosenberg 1999) .
Admixture Disequilibrium Tests
The admixture of genetically distinct populations can generate LD throughout the genome (Nei and Li 1973) and is often considered a liability in disequilibrium mapping. However, admixture can potentially be turned to an advantage because, following an admixture event, disequilibrium will decay as a function of the distance between a disease-causing gene and marker loci (Chakraborty and Weiss 1988) . Several approaches have been devised to assess admixturegenerated disequilibrium (Kaplan et al. 1998; McKeigue 1997; McKeigue 1998) . Because many human populations have undergone extensive recent admixture (e.g., Hispanics in the United States), there are a number of potential candidates for admixture disequilibrium mapping. Important requirements for successful application of this approach are that the parental populations should show relative genetic homogeneity and that their allele frequencies should differ substantially . This is often not the case in major human populations (e.g., African-Americans in whom the parental African population is highly diverse) (Dean et al. 1994 ). Further complications arise from the fact that admixture in modern human populations is seldom limited to a specific point in history but instead is a continuing process. 
Multilocus Disequilibrium Methods
As in traditional linkage analysis, the incorporation of information from multiple loci can enhance the power and accuracy of LD mapping. An early and popular method for using multilocus data was devised by Terwilliger (1995) . This method uses a LD measure, , that is very similar to the ␦ statistic discussed above (Devlin and Risch 1995) . The values for each marker and the disease locus are used to form marginal log-likelihoods, which are then summed to yield a multipoint test for LD. Another multipoint method has been formulated by Devlin et al. (1996) . This composite likelihood approach attempts to take evolutionary variance (i.e., drift effects) into account and is thus potentially more realistic than Terwilliger's method. Xiong and Guo (1997) propose an elegant multipoint method in which a Taylor series expansion is used to approximate the likelihood. The advantages of this method are that multiple mutations at marker and disease loci can be accommodated, as well as variable models of population growth. However, this method, like those of Terwilliger and Devlin et al., does not account for covariance among markers (McPeek and Strahs 1999) , and the Taylor series approximation may sometimes be inadequate (Rannala and Slatkin 1998) . Another composite likelihood method is based on the Malécot isolation-by-distance model . This method, which is derived from well-developed theory, accommodates multiple founder mutations and easily allows the pooling of heterogeneous data from multiple studies. Application of this method to various data sets Lonjou et al. 1998) indicates a relatively high level of resolving power. Lazzeroni (1998) has formulated a least-squares approach in which piecewise nonlinear regression is used to fit a curve to the pattern of ␦ values for diallelic polymorphisms in the region containing a disease-causing locus. This curve predicts the most likely location of the locus. A bootstrap approach is used to estimate the sampling distribution of ␦ so that the covariance structure of the markers is taken into account. This method can be extended to accommodate multiple founder mutations and locus heterogeneity.
A related form of multilocus disequilibrium mapping involves the statistical analysis of haplotype regions shared in affected cases. Because these approaches are based on haplotypes rather than single marker loci, the relationships among groups of markers are necessarily taken into account. Service et al. (1999) propose a likelihood method that compares the distribution of haplotypes among cases with the distribution expected if all affected individuals are descended from a common ancestor who carried a disease-causing mutation. Computer simulations indicate that this method has greater power to detect disease-causing mutations under conditions of moderate heterogeneity than do methods such as those of Terwilliger; thus, this approach may be more useful in detecting loci underlying complex disease susceptibility. Another haplotype-sharing approach (McPeek and Strahs 1999) uses a coalescent model to account for the effects of population structure on covariance between marker loci. The ancestral haplotype that contains a diseasecausing mutation is inferred, and a likelihood curve provides the estimated location of the disease locus and associated confidence limits. Yet another method (Lam et al. 2000) uses maximum parsimony to build an evolutionary phylogeny of disease haplotypes. Mutation and recombination probabilities are incorporated into the model, and various possible locations of a disease-causing mutation are evaluated by comparing likelihoods of evolutionary trees.
Strategies for Mapping Complex Disease Genes
Having reviewed many of the statistical techniques that can be used to estimate LD, we turn now to several issues relevant to the design and execution of LD-based mapping studies. Because of the current focus on mapping complex disease genes, special attention is focused on this area.
Statistical Power and Efficiency
The power and efficiency of LD statistics are affected by the methods used, the number of available samples, mode of inheritance, the patterns of recombination and mutation in a region, the age of the mutation(s), the degree of locus and allelic heterogeneity, the type of markers assayed, and many aspects of population history (Chapman and Wijsman 1998; Kaplan et al. 1997; Long and Langley 1999; Morton and Collins 1998; Page and Amos 1999; Risch and Merikangas 1996; Schaid 1998; Teng and Risch 1999; Xiong and Guo 1998; Xiong and Jin 1999; Zöllner and von Haeseler 2000) . Because of this complexity, it is unlikely that a single technique or approach will provide optimal power under all circumstances. Power to detect LD tends to be greatest when a single disease-causing mutation that accounts for a large proportion of the phenotypic variance of a trait has arisen recently on a relatively uncommon haplotype background. These conditions promote large differences in marker allele frequencies in mutation carriers versus noncarriers. Locus and allelic heterogeneity, which are common in complex diseases, can produce dramatic decreases in power (Xiong and Guo 1998) . Mutations responsible for complex diseases will often persist for long periods of time because they are typically less subject to the effects of natural selection than are mutations responsible for Mendelian diseases (Terwilliger and Weiss 1998) . This can further diminish LD and the resultant power to detect it.
Often, judicious study design will have a greater effect on statistical power than will the choice of analytic technique (Terwilliger and Göring 2000) . Power may be increased substantially, for example, by minimizing environmental variance and by attempting to maximize a genetic signal through the selection of extreme phenotypes (Long and Langley 1999) . As with traditional linkage analysis, the effects of locus heterogeneity can be decreased through careful definition of the disease phenotype.
As marker density continues to increase, and as genotyping costs decrease, whole genome scans for allelic associations are becoming feasible (Kruglyak 1997; Kruglyak 1999; Risch and Merikangas 1996) . However, the volume of genotyping in such studies can be enormous, particularly if the number of cases is large. Pooling the DNA of cases and of controls and then estimating marker allele frequencies in each of the pooled samples can cut costs considerably (Arnheim et al. 1985) . This approach will allow the reliable detection of allele frequency differences of ∼5% (Shaw et al. 1998 ), but, because heterozygous genotypes cannot be identified, the TDT cannot be used directly with pooled DNA samples. Instead, case-control approaches or the haplotype relative risk method may be used, provided that ethnic stratification is not a factor (Risch and Teng 1998; Shaw et al. 1998 ).
Marker Characteristics
Most often, LD studies are carried out using microsatellite polymorphisms and/or SNPs. Because of its multiple alleles, one microsatellite usually provides more information for linkage analysis than does one SNP, but the situation is more complex for LD. Here, factors such as the age of the disease-causing mutation(s), mutation rate of the marker, mode of inheritance of the disease, and recombination distance between marker and disease loci will all influence power to detect LD. For example, the higher mutation rate of microsatellites will generally cause LD to decrease more rapidly; this effect will become more significant at small genetic distances, when mutation rates and recombination rates are similar in magnitude (Xiong and Jin 1999) . Thus, the elevated microsatellite mutation rate will often result in a decrease in statistical power, unless a disease-causing mutation has arisen on a chromosome that contains a newly created microsatellite allele (producing a strong association and an increase in power). As a result of differences in models and assumptions, comparisons of the two types of markers have arrived at somewhat differing conclusions (Chapman and Wijsman 1998; Xiong and Jin 1999) . It is clear, in any case, that the use of haplotypes containing multiple SNPs will increase the power to detect LD (Ott and Rabinowitz 1997; Zöllner and von Haeseler 2000) . However, less information, and thus less power, will be contributed if the SNPs are in strong LD with one another. Currently, many SNPs are being ascertained on the basis of relatively high heterozygosity in a multiethnic panel of individuals ). Although high heterozygosity will generally increase the power to detect LD, SNPs that are highly polymorphic in most major human populations are likely to be ancient. Consequently, many generations will have elapsed during which LD between these SNPs and nearby disease-causing mutations can dissipate, reducing the power to detect LD. In at least some situations, younger SNPs with lower overall heterozygosity or a more restricted distribution in populations may therefore be preferable .
The density of markers required for effective association-based mapping is the subject of some controversy. A recent simulation study indicated that LD between mutations underlying complex diseases and surrounding SNPs may become nonsignificant after only 3 kb (Kruglyak 1999) . However, this simulation did not consider the effects of natural selection, which will limit the persistence of disease-causing mutations in populations and decrease the length of time during which LD can dissipate. In addition, realistic demographic scenarios, such as recurrent population expansions, can produce much larger regions of disequilibrium Thompson and Neel 1997) . Importantly, a number of empirical studies of the extent of LD have now been performed on various outbred human populations, and most of these reveal significant disequilibrium for some locus pairs separated by at least 30-50 kb and often for loci separated by considerably greater distances Goddard et al. 2000; Huttley et al. 1999; Jorde et al. 1994; Jorde et al. 2000; Kidd et al. 1998; Peterson et al. 1995; Watkins et al. 1994) .
These empirical studies, as well as a recent study of a 9.7kb region in the LPL gene (Nickerson et al. 1998) , show that levels of LD are quite variable in small genomic regions, ranging from highly significant to nonsignificant. In this context, it is important to keep in mind that the sampling variance of LD statistics becomes large in such regions (Golding 1984; Hudson 1985) . In addition, these statistics can be strongly affected by evolutionary variance (i.e., the effects of stochastic factors such as genetic drift). On this basis alone, it is expected that closely linked sites (e.g., those <30-50 kb apart) will often fail to demonstrate significant LD and that LD is unlikely to provide an accurate prediction of the physical distance between closely linked sites (Jorde 1995; Jorde et al. 1994 ).
Choice of Populations
Because LD reflects the history of recombination, populations with different demographic histories will often display different LD patterns. Although population comparisons of LD patterns are still relatively few, some generalizations can be made. In particular, most studies demonstrate higher levels of LD in recently founded populations than in "older" populations such as those in Africa (Jorde et al. 2000; Kidd et al. 1998; Kunst et al. 1996; Lonjou et al. 1999; Purandare et al. 1996; Tishkoff et al. 1996; Tishkoff et al. 1998) . In recently founded groups, such as the Finnish (Peltonen 2000) or Mennonite populations (Puffenberger et al. 1994) , LD may be seen for loci separated by several cM or more. These patterns have led to the suggestion that younger populations may be most useful for the initial detection of a disease locus via LD at large distances. Subsequently, older populations, in which more recombinants have accumulated, may be more useful for the fine-scale LD mapping of the disease locus. This approach assumes that the ages of disease-causing mu-tations are correlated with the age of a population (i.e., that most major mutations arose near the time of the founding of the population). In addition, for complex diseases, it assumes that the relative effect of each susceptibility locus will be roughly similar in diverse populations, allowing one to extrapolate from an initial result in a young population to a fine-scale mapping effort in an older population.
Encouraged by the singular successes of LD-based mapping of Mendelian disorders in isolated populations (de la Chapelle and Wright 1998), many investigators are now turning to these populations in the search for loci underlying complex diseases (Peltonen 2000; Sheffield et al. 1998; Wright et al. 1999 ). The reasoning is simple: isolated populations typically have a simpler population history, with fewer founders and less population admixture. In effect, the ideal isolated population is a large pedigree with many, many generations. Therefore, it is expected that allelic and locus heterogeneity should be more limited, permitting easier detection of allelic associations.
This paradigm is not without its critics, however Terwilliger and Weiss 1998) . While allelic heterogeneity is often reduced for rare Mendelian diseases in isolated populations, it is unknown whether a similar reduction will be seen for loci underlying oligogenic disorders. For a relatively common disease that requires the contribution of, say, 3-5 predisposing loci, the total frequency of disease-causing variants in each oligogene would be relatively high. Only the most severe bottleneck, with a reduction to perhaps 10-100 unrelated individuals, would substantially reduce the number of disease-causing alleles at such a locus (Kruglyak 1999) . Other difficulties with isolated populations are: (1) a potentially high level of background inbreeding, which decreases heterozygosity and hence the efficiency of the TDT ; (2) limitations on the sample size of unrelated (or, more precisely, distantly related) mutationcontaining chromosomes (Bonné-Tamir et al. 1997) ; and (3) often, a relatively short population history, which will tend to increase the distance at which LD can be found but decrease the level of resolution of LD mapping (i.e., the length of shared haplotype segments in mutation-containing chromosomes tends to be large). Further discussion of these issues can be found elsewhere (Jorde et al. 2000) . On the other hand, isolates are less likely to have experienced repeated admixture events, which can obscure disequilibrium signals. Also, they are more likely to have a relatively homogeneous environment, which should help to decrease the undesirable effects of factors such as phenocopies and reduced penetrance.
Many isolated populations have experienced rapid population growth in recent times. Indeed, genetic signatures of major population expansions are detectable in most human populations (Harpending et al. 1998) . Rapid growth limits LD because genetic drift is minimal in such populations. This suggests that small, isolated populations of constant size, in which genetic drift can produce substantial LD (Slatkin 1994) , may be especially effective in detecting complex disease loci (Laan and Pääbo 1997; Zöllner and von Haeseler 2000) . It remains to be seen whether many human populations meet the criteria of isolation, sufficient constancy of population size, and a sufficient number of unrelated disease haplotypes.
The ultimate test of the usefulness of isolates for mapping complex diseases will come from empirical data on the extent of locus and allelic heterogeneity in these populations. To date, such data are rare. One recent genome-wide scan for schizophrenia genes in an isolated Finnish subpopulation found evidence of multiple loci but no evidence, thus far, of LD (Hovatta et al. 1999) . A population comparison of allelic diversity in the LPL locus, which can be considered a gene underlying susceptibility to a common disease, showed that allelic diversity is nearly as high in a Finnish population as in an outbred U.S. population (Nickerson et al. 1998) . Clearly, additional data are needed on allelic and locus heterogeneity in isolated human populations and on patterns of LD in a variety of human populations.
Conclusion
The past decade has witnessed a burgeoning development of methods for the analysis of LD. Investigators are no longer limited to a few frequency-dependent measures of simple LD. Several approaches now deal with nettlesome problems like population stratification. Techniques have also been developed to exploit specific attributes of some populations, such as admixture. Importantly, several new multilocus methods have been formulated, and these will become increasingly useful as more polymorphic markers accumulate.
As human geneticists move from the mapping of relatively tractable Mendelian conditions to the identification of loci underlying complex diseases, the usefulness of LD approaches remains an open question. Further methodological developments will be needed to deal effectively with the complexity underlying common disease. However, effective experimental design will be at least as important in determining the success of LD mapping for these diseases. Researchers must learn enough about the demographic history of a population to determine its usefulness for LD mapping, and they must design case-control or family studies to achieve maximum power and efficiency. The optimal choice of populations will depend on the distribution of genetic variation in populations, which in turn affects allelic and locus heterogeneity. Our understanding of this variation, and the factors that influ-ence it, is still rudimentary and will require a thorough sampling of human genetic diversity. This information, combined with further methodological developments and well-informed study design, offer hope for the success of LD approaches in the search for complex disease genes.
